Expression of the Wilms' Tumor Gene (WT1) in Human Leukemias

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 1992 May 1

PMID 1317488

Citations 93

Authors

H Miwa

M Beran

G F Saunders

Affiliations

Soon will be listed here.

Abstract

Leukemic cells from seventy patients with various types of human leukemias were examined for expression of the WT1 gene, the Wilms' tumor gene located at chromosome 11p13. WT1 was expressed in 7 of 16 cases of acute lymphoblastic leukemia, 15 of 22 with acute myelogenous leukemia and 8 of 10 in blast crisis of chronic myelogenous leukemia. No detectable WT1 RNA was found in chronic leukemias, including chronic lymphocytic leukemia, plasma cell leukemia, hairy cell leukemia and chronic myelogenous leukemia in chronic phase. The expression pattern of WT1 in these human leukemia samples indicates the involvement of this gene in the early stage of hematological cell differentiation.

Citing Articles

Precision Medicine in Myeloid Neoplasia: Challenges and Opportunities.

Hochman M, Muniz J, Papadantonakis N J Pers Med. 2025; 15(2).

PMID: 39997326 PMC: 11856194. DOI: 10.3390/jpm15020049.

Assessment of the carcinogenic potential of particulate matter generated from 3D printing devices in Balb/c 3T3-1-1 cells.

Lim C, Seo D Sci Rep. 2024; 14(1):23981.

PMID: 39402095 PMC: 11473660. DOI: 10.1038/s41598-024-75491-1.

Role of WT1 in Measurable Residual Disease Follow-Up in the Post Allogeneic Stem Cell Transplant Setting.

Namdaroglu S, Basci S, Aslan Candir B, Yaman S, Yigenoglu T, Bahsi T J Clin Med. 2024; 13(17).

PMID: 39274359 PMC: 11396114. DOI: 10.3390/jcm13175145.

Upregulation of HOXA3 by isoform-specific Wilms tumour 1 drives chemotherapy resistance in acute myeloid leukaemia.

Allen B, Savoy L, Ryabinin P, Bottomly D, Chen R, Goff B Br J Haematol. 2024; 205(1):207-219.

PMID: 38867543 PMC: 11448753. DOI: 10.1111/bjh.19563.

Dysregulated Expression of MiR-19b, MiR-25, MiR-17, WT1, and CEBPA in Patients with Acute Myeloid Leukemia and Association with Graft versus Host Disease after Hematopoietic Stem Cell Transplantation.

Iravani Saadi M, Tahmasebijaroubi F, Noshadi E, Rahimikian R, Karimi Z, Owjfard M South Asian J Cancer. 2023; 11(4):346-352.

PMID: 36756106 PMC: 9902101. DOI: 10.1055/s-0042-1742593.